Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

University of Pittsburgh recruits patients for Somnoplasty clinical trial

Oct. 7, 1998

FDA approves Serevent Diskus for maintenance treatment of pediatric asthma

Oct. 7, 1998

Dura and Spiros update development of Spiros products

Oct. 1, 1998

AxyS Pharmaceuticals discontinues development of APC-366 for asthma

Sep. 30, 1998

Dual LTD4 antagonists/histamine release inhibitors in development at Daiichi

Sep. 30, 1998

LCB-2183 inhibits mast cell activation in vivo in mice

Sep. 29, 1998

Clinical trial results for Ariflo presented at European congress

Sep. 29, 1998

Zeneca's CysLT1 antagonist shows potential for once-daily dosing; efficacy studies warranted

Sep. 29, 1998

V-11294A: an orally active PDE4 inhibitor undergoes testing in healthy volunteers

Sep. 29, 1998

Shionogi describes new PGD2 antagonists for allergic and inflammatory disorders

Sep. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026